Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial
Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial have?
Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial has 272 citations in the OpenAlex counts ScholarIQ stores.
When was Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial published?
Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial has 2015 year in the ScholarIQ index.
What is the open-access status of Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial?
Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial has bronze oa status in the ScholarIQ index.
What is the DOI of Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial?
The DOI for Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial is on the source record.
What is the PMID of Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial?
The PMID for Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial is on the source record.
What is the OpenAlex record for Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial?
The OpenAlex for Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial is on the source record.